Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
norepinephrine/obezita
Odkaz je uložen do schránky
Strana 1 z 19 Výsledek
Method and composition for treating obesity, drug abuse, and narcolepsy
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
This invention relates to compositions comprising a norepinephrine precursor, such as L-tyrosine or L-phenylalanine in combination with a norepinephrine re-uptake inhibitor such as desipramine. The compositions are useful in controlling obesity, depression, drug abuse, and
Low dosage combinations of fluoxetine and reboxetine for treating obesity
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition for improved treatment of obesity. In particular, the present invention relates to compositions comprising a combination of norepinephrine reuptake inhibitors and selective serotonin reuptake inhibitors, and use
Serotonin and norepinephrine reuptake inhibitors and uses thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
The market for neuroscience and women's health drugs has been moving towards the use of dual serotonin and norepinephrine reuptake inhibitors (SNRI) for first line treatment of various indications, as evidenced by the recent development of SNRI's such as Venlafaxine and
Serotonin and norepinephrine reuptake inhibitor and uses thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
The market for neuroscience and women's health drugs has been moving towards the use of dual serotonin and norepinephrine reuptake inhibitors (SNRI) for first line treatment of various indications, as evidenced by the recent development of SNRI's such as Venlafaxine and
Method for treating obesity
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD
The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight-loss promoting anticonvulsant either alone or in combination with
Method for treating obesity
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD
The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight-loss promoting anticonvulsant either alone or in combination with
Method for treating obesity
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD
The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight-loss promoting anticonvulsant either alone or in combination with
Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract, in other words, a yeast extract or yeast-derived bioactive peptide having an activity of selectively inhibiting
Monoamine reuptake inhibitors
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present application is directed to various compounds and methods of preparation of compounds that are capable of functioning as monoamine reuptake inhibitors. The application is also directed to pharmaceutical compositions containing one or more monoamine reuptake
Hydroxybupropion analogues for treating drug dependence
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present application is directed to various compounds and methods of preparation of compounds that are capable of functioning as monoamine reuptake inhibitors and/or as antagonists of nicotinic acetylcholine receptors. The application is also directed to pharmaceutical
Hydroxybupropion analogues for treating drug dependence
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present application is directed to various compounds and methods of preparation of compounds that are capable of functioning as monoamine reuptake inhibitors and/or as antagonists of nicotinic acetylcholine receptors. The application is also directed to pharmaceutical
Ligands for monoamine receptors and transporters, and methods of use thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in
Ligands for monoamine receptors and transporters, and methods of use thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in
Ligands for monoamine receptors and transporters, and methods of use thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in
4-substituted piperidines, and methods of use thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in
Nejúplnější databáze léčivých bylin podložená vědou
- Funguje v 55 jazycích
- Bylinné léky podporované vědou
- Rozpoznávání bylin podle obrázku
- Interaktivní mapa GPS - označte byliny na místě (již brzy)
- Přečtěte si vědecké publikace související s vaším hledáním
- Hledejte léčivé byliny podle jejich účinků
- Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty
Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu
